India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap
India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap
<iframe src="https://hindustansphere.com/embed/cluster/94bf27ed56d58ed2ba925e59ef1c0a2e9b8047a5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Who decides the cost of medicines in India?"></iframe>
India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap
